Recombinant Cynomolgus GSTP1 Protein, His-tagged

• Cat.No.: GSTP1-580C
• Product Overview: Recombinant Cynomolgus GSTP1 full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Cynomolgus
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: GSTP1 glutathione S-transferase pi 1 [ Macaca fascicularis (crab-eating macaque) ]
• Official Symbol: GSTP1
• Synonyms: GSTP1; glutathione S-transferase P1
• Gene ID: 102127415
• mRNA Refseq: NM_001289964
• Protein Refseq: NP_001276893
• UniProt ID: A0A023JCR5

Reviews

11/16/2021

the GSTP1 protein is of the highest quality and perfectly suited for your experimental requirements.

07/24/2018

The GSTP1 protein is an exceptional choice that meets the highest standards of quality, making it perfectly suited for your experimental needs.

12/01/2016

In addition to its exceptional quality, the GSTP1 protein is backed by excellent technical support offered by the manufacturer.

Q&As

Can GSTP1 genetic variants affect drug metabolism?

Yes, genetic polymorphisms in GSTP1 can influence an individual's response to certain drugs, impacting their effectiveness and potential side effects.

Can GSTP1 levels change with age?

GSTP1 levels may vary with age, as the enzyme's expression can be influenced by factors such as hormonal changes and environmental exposures.

In what cancers is GSTP1 commonly studied?

GSTP1 is frequently studied in prostate cancer, but it is also relevant in breast, lung, and other cancers.

Are there diagnostic tests to assess GSTP1 levels?

Yes, clinical laboratories can measure GSTP1 expression levels using various molecular techniques, such as PCR and immunohistochemistry.

What are the potential future developments in GSTP1-based clinical applications?

Future developments may include personalized medicine approaches that consider an individual's GSTP1 genetic profile for optimizing treatment regimens.